Studies by Papathomas et al. showed that immunohistochemistry for SDHB was a reliable surrogate marker of SDHx mutation despite that the SDHB-immunonegative subset of VHL- and NF1-mutated paraganglionic tumors may influence the specificity (65). The gene discussed is VHL; the disease is paraganglioma.